期刊文献+

高原地区慢性肺源性心脏病患者肺血管活性因子水平变化及其与肺动脉高压的关系 被引量:2

Changes of pulmonary vasoactive factors and its relation with pulmonary arterial hypertension in patients with chronic cor pulmonale at high altitude area
原文传递
导出
摘要 目的探讨高原慢性肺心病(HACCP)患者肺血管活性因子变化及其与肺动脉高压(PAH)的关系。方法采用放射免疫分析法检测65例HACCP急性加重期和60例缓解期患者血浆中介素(IMD)、肾上腺髓质素(ADM)、内皮素-1(ET-1)含量,用血气分析仪测定动脉血氧分压(PaO2),用多普勒超声心动仪测定肺动脉血流频谱,计算平均肺动脉压(mPAP),并与40例当地健康人比较。结果 HACCP急性加重期和缓解期患者血浆IMD、ADM、ET-1及mPAP[分别为(156.6±15.2)pg/mL、(71.7±6.3)pg/mL、(90.8±9.5)ng/L、(44.7±6.5)mmHg和(112.3±12.5)pg/mL、(47.8±4.2)pg/mL、(64.9±6.6)ng/L、(34.9±5.2)mmHg]较对照组[分别为(60.6±9.8)pg/mL、(21.8±3.2)pg/mL、(34.8±4.3)ng/L、(21.2±3.4)mmHg]显著升高,PaO2[分别为(36.4±5.3)mmHg、(48.8±4.4)mmHg]较对照组[(68.2±3.5)mmHg]显著降低(均P<0.01)。急性加重期与缓解期比较亦有非常显著性差异(均P<0.01)。急性加重期及缓解期患者mPAP与血浆IMD、ADM、ET-1均呈显著正相关(分别r=0.688、0.719、0.723及0.569、0.591、0.627,均P<0.01),PaO2与IMD、ADM、ET-1均呈显著负相关(分别r=-0.625、-0.698、-0.638及-0.641、-0.536、-0.562,均P<0.01)。结论 IMD、ADM、ET-1共同参与了HACCP患者PAH形成的病理生理过程,其比例失衡可能是导致高原肺心病低氧性PAH发生发展的重要因素。 Objective To assess the changes of pulmonary vasoactive factors and its relation with pulmonary arterial hypertension (PAH) in patients with chronic cor pulmonale at high alti- tude (HACCP) area. Methods The levels of plasma intermedin(IMD) , adrenomedulin( ADM), endothelin-1 (ET-1) , partial pressure of oxygen in artery blood (PaO2 ) , and mean pulmonary arte- rial pressure (mPAP)were measured in 65 patients with exacerbation and 60 patients with stable HACCP, the upper mentioned parameters were meated in 40 healthy peoples. Results Levels of plasma IMD,ADM,ET-1 ,and mPAP in patients with exacerbation and stable HACCP [ (156.6 ± 15.2)pg/mL,(71.7 ±6.3)pg/mL,(90.8 ±9.5)ng/L,(44.7 ±6.5)mm Hg and(112.3 ±12.5) pg/mL, (47.8 ± 4.2 ) pg/mL, ( 64.9 ± 6.6 ) ng/L, ( 34.9 + 5.2 ) mm Hg, respectively ] were both markedly higher, and PaO2 [ ( 36.4 ± 5.3 ) mm Hg, ( 48.8 ± 4.4 ) mm Hg, respectively ] was bothmarkedly lower than those in the the normal control subjects [ (60.6 ± 9.8 )pg/mL, (21.8 ± 3.2) pg/mL, (34.8 ± 4.3 ) ng/L, (21.2± 3.4) mm Hg, (68.2 ± 3.5 )mm Hg , respectively ] ( all P 〈 0.01 ), all parameters in patients with exacerbation HACCP were different significantly compared with those in patients with stable HACCP ( all P 〈 0.01 ). The mPAP was both positively eorreled with IMD,ADM,ET-1 (r =0. 688,0. 719,0. 723 and 0. 569,0. 591,0. 627,respectively ,all P 〈 0.01 ), and PaO2 was both netatively correlated with IMD, ADM, ET-1 ( r = - 0. 625, - 0. 698, - 0.638 and - 0. 641, - 0. 536, - 0.562, respectively, all P 〈 0.01 ) in patients with exacerbation and stable HACCP. Conclusion IMD, ADM and ET-1 may play important roles in mechanism of PAH in HACCP. Imbalance of these factors have great effeets on the development of hypoxie pulmonary hypertasion in HACCP.
出处 《中华肺部疾病杂志(电子版)》 CAS 2011年第3期38-42,共5页 Chinese Journal of Lung Diseases(Electronic Edition)
关键词 肺疾病 慢性阻塞性 肺动脉高压 中介素 内皮素 肾上腺髓质素 高原地区 Chronic obstructive pulmonary disease Intermedin Endothelin-1 Adrenomedulin Pulmonary artery hypertension obstructive Highaltitude area
  • 相关文献

参考文献13

二级参考文献54

共引文献99

同被引文献28

  • 1董锦华,赵凯.不同方法治疗慢性阻塞性肺疾病合并呼吸衰竭74例对比观察[J].陕西医学杂志,2008,37(7):830-831. 被引量:5
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 3Chen JJ, Sun Y, Nabel GJ. Regulation of the proinflammatory effects of Fas ligand ( CD95 L) [J]. Science, 1998, 282 ( 5394 ) : 1714- 1717.
  • 4Chen H, Wang Y, Bai C, et al. Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbation[ J]. J Proteornics, 2012, 75(10) : 2835-2843.
  • 5Hsing CH, Chiu CJ, Chang LY, et al. IL-19 involved in the pathogenesis of endotoxic shock[J]. Shock, 2008, 29 (1): 7-15.
  • 6Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy-review of a new approach[J]. Pharmaccol Rev, 2003, 55(2) : 241-269.
  • 7Xerri L, Devilard E, Hassoun J, et al. Fas ligand is not only expressed in immune privileged human organs but is also coexp ressed with Fas in various ep ithelial tissues[J]. Mol Pathol, 1997, 50 (2) : 87-91.
  • 8Kulkami AB, Karlsson S. Inflammation and TGF beta 1: lessons from the TGF beta 1 null mouse[ J]. Res immunol, 1997, 148(7) : 453 -456.
  • 9Bames PG, Chowdhury B, Kharitonov SA. et al. Pulmonary biomarkers in chronic obstructive pulmonary disease[J]. Am J Respir Crit CareMed, 2006, 174(1) : 6-14.
  • 10李继东,肖永久,朱运奎,薛庆亮,王舒,王晓芹,刘卫.纤维支气管镜引导下经鼻气管插管治疗慢性阻塞性肺疾病并呼吸衰竭临床应用[J].中国内镜杂志,2008,14(2):119-120. 被引量:13

引证文献2

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部